Top

Published in:

01-12-2013 | Editorial

The Editorial for this Special Issue

Authors: Donald DeGracia, Bingren Hu

Published in: Translational Stroke Research | Issue 6/2013

Excerpt

This special issue of Translational Stroke Research focusing on “Protein Misfolding and Organelle Stress after Brain Ischemia” grew, in part, from a symposium presented at the XXVth International Symposium on Cerebral Blood Flow, Metabolism and Function held in Barcelona, Spain, in May of 2011. Both that symposium and this special issue seek to raise awareness in the field of how brain ischemia as a multifactorial condition affects all subcellular organelles. …

Liu CH, Zhang F, Krisrian K, Polster B, Fiskum GM, Hu BR. Protein aggregation and multiple organelle damage after brain ischemia. In: Lapchak, PA, Zhang JH, editors. Translational stroke research: from target selection to clinical trials. New York: Springer; 2012. p. 101–116.

Yu CY, Ng G, Liao P. Therapeutic antibodies in stroke. Transl Stroke Res. 2013;4:477–83.PubMedCrossRef

Yu SP, Wei Z, Wei L. Preconditioning strategy in stem cell transplantation therapy. Transl Stroke Res. 2013;4(1):76–88.PubMedCrossRef

Ostrowski RP, Schulte RW, Nie Y, Ling T, Lee T, Manaenko A, et al. Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model. Transl Stroke Res. 2012;3(4):473–81.PubMedCrossRef

Kuroda S, Houkin K. Translational challenge for bone marrow stroma cell therapy after stroke. Front Neurol Neurosci. 2013;32:62–8.PubMedCrossRef

Phillips AW, Johnston MV, Fatemi A. The Potential for cell-based therapy in perinatal brain injuries. Transl Stroke Res. 2013;4(2):137–48.PubMedCrossRef

Sävman K, Heyes MP, Svedin P, Karlsson A. Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia. Transl Stroke Res. 2013;4(2):228–35.PubMedCrossRef

Stridh L, Ek CJ, Wang X, Nilsson H, Mallard C. Regulation of toll-like receptors in the choroid plexus in the immature brain after systemic inflammatory stimuli. Transl Stroke Res. 2013;4(2):220–7.PubMedCrossRef

Tajiri N, Dailey T, Metcalf C, Mosley YI, Lau T, Staples M, et al. In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res. 2013;4(3):308–21.PubMedCrossRef

10.

Leung PY, Hurst S, Berny-Lang MA, Verbout NG, Gailani D, Tucker EI, et al. Inhibition of factor XII-mediated activation of factor xi provides protection against experimental acute ischemic stroke in mice. Transl Stroke Res. 2012;3(3):381–9.PubMedCrossRef

11.

Herson PS, Palmateer J, Hurn PD. Biological sex and mechanisms of ischemic brain injury. Transl Stroke Res. 2013;4(1):413–9.PubMedCrossRef

12.

Fisher M, Vasilevko V, Cribbs DH. Mixed cerebrovascular disease and the future of stroke prevention. Transl Stroke Res. 2012;3 Suppl 1:39–51.PubMedCrossRef

13.

DeGracia DJ, Huang ZF, Huang S. A nonlinear dynamical theory of cell injury. J Cereb Blood Flow Metab. 2012;32(6):1000–13.PubMedCrossRef

Title: The Editorial for this Special Issue
Authors: Donald DeGracia
Bingren Hu
Publication date: 01-12-2013
Publisher: Springer US
Published in: Translational Stroke Research / Issue 6/2013
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-013-0302-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Editorial for this Special Issue

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2013

ER Stress and Effects of DHA as an ER Stress Inhibitor

Heat Shock Proteins in the Brain: Role of Hsp70, Hsp 27, and HO-1 (Hsp32) and Their Therapeutic Potential

Mitochondrial Dysfunction and NAD+ Metabolism Alterations in the Pathophysiology of Acute Brain Injury

Fission and Fusion of the Neuronal Endoplasmic Reticulum

Lysosomal Membrane Permeabilization as a Key Player in Brain Ischemic Cell Death: a “Lysosomocentric” Hypothesis for Ischemic Brain Damage

Fast Neuroprotection (Fast-NPRX) for Acute Ischemic Stroke Victims: the Time for Treatment Is Now